At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.
Close
HSCS HeartSciences Inc
Trading 11-04 13:49:14 EST
3.17
+0.22
+7.29%
High3.26Low3.02Vol49.25K
Open3.02D1 Closing2.95Amplitude8.14%
Mkt Cap15.19MTradable Cap11.47MTotal Shares4.80M
T/O156.54KT/O Rate1.36%Tradable Shares3.62M
P/B--ROE--EPS0.00
52wk High--52wk Low--P/E--
Dividend--Div.Yield--ROA--

Loading ...

HeartSciences sets November 19 vote on Fortitude Mining combination
TIPRANKS  ·  10-21
HeartSciences sets November 19 vote on Fortitude Mining combination
Heartsciences Files Definitive Proxy Statement for Proposed Business Combination with Fortitude Mining
THOMSON REUTERS  ·  10-21
Heartsciences Files Definitive Proxy Statement for Proposed Business Combination with Fortitude Mining
Heartsciences - Board Unanimously Recommends Shareholders Vote for Deal Proposals
THOMSON REUTERS  ·  10-21
Heartsciences - Board Unanimously Recommends Shareholders Vote for Deal Proposals
Press Release: HeartSciences Files Definitive Proxy Statement for Proposed Business Combination with Fortitude Mining
Dow Jones  ·  10-21
Press Release: HeartSciences Files Definitive Proxy Statement for Proposed Business Combination with Fortitude Mining
HeartSciences Wins FDA 510(k) Clearance for MyoVista wavECG Device
Reuters  ·  10-06
HeartSciences Wins FDA 510(k) Clearance for MyoVista wavECG Device
Heartsciences - Receives FDA 510(k) Clearance for Myovista Wavecg Device
THOMSON REUTERS  ·  10-06
Heartsciences - Receives FDA 510(k) Clearance for Myovista Wavecg Device
Heartsciences - Expects to Close Business Combination with Fortitude in Q4 2026
THOMSON REUTERS  ·  10-06
Heartsciences - Expects to Close Business Combination with Fortitude in Q4 2026
Heartsciences - Does not Intend to Commercialize Device Without Cleared AI-Ecg Algorithm
THOMSON REUTERS  ·  10-06
Heartsciences - Does not Intend to Commercialize Device Without Cleared AI-Ecg Algorithm
Heartsciences - Clearance Covers Ecg Signals from Adult and Pediatric Patients; Excludes AI-Ecg Algorithm
THOMSON REUTERS  ·  10-06
Heartsciences - Clearance Covers Ecg Signals from Adult and Pediatric Patients; Excludes AI-Ecg Algorithm
Top Premarket Decliners
MT Newswires Live  ·  10-06
Top Premarket Decliners
Fortitude: Dcg May Provide Additional Zec Funding to Fortitude Through FY 2027
THOMSON REUTERS  ·  10-06
Fortitude: Dcg May Provide Additional Zec Funding to Fortitude Through FY 2027
Fortitude Secures Priority Supply Allocation for Bitmain’s Next-Generation Zcash Mining Equipment, Announces $100 Million Non-Binding Purchase Commitment, and Additional Upsizing of Dcg Credit Facility and Available Zec Funding from Dcg
THOMSON REUTERS  ·  10-06
Fortitude Secures Priority Supply Allocation for Bitmain’s Next-Generation Zcash Mining Equipment, Announces $100 Million Non-Binding Purchase Commitment, and Additional Upsizing of Dcg Credit Facility and Available Zec Funding from Dcg
Fortitude- Dcg Credit Facility Commitment Increased to $70 Mln to Support Potential Investment, with $20 Million Draw in Zec Planned in Near Term
THOMSON REUTERS  ·  10-06
Fortitude- Dcg Credit Facility Commitment Increased to $70 Mln to Support Potential Investment, with $20 Million Draw in Zec Planned in Near Term
Fortitude: Bitmain Next-Gen Zcash Mining Equipment Expected to Ship in Q2 2027
THOMSON REUTERS  ·  10-06
Fortitude: Bitmain Next-Gen Zcash Mining Equipment Expected to Ship in Q2 2027
HeartSciences Extends USD 500,000 Front Range Ventures Loan Maturity to Jan. 29, 2027
Reuters  ·  10-03
HeartSciences Extends USD 500,000 Front Range Ventures Loan Maturity to Jan. 29, 2027
Fortitude Appoints Kimberly Pittman as Chief Legal Officer
THOMSON REUTERS  ·  09-30
Fortitude Appoints Kimberly Pittman as Chief Legal Officer
HeartSciences files $200M mixed securities shelf
TIPRANKS  ·  09-26
HeartSciences files $200M mixed securities shelf
Heartsciences - May Issue up to $200 Mln of Securities - SEC Filing
THOMSON REUTERS  ·  09-26
Heartsciences - May Issue up to $200 Mln of Securities - SEC Filing
HeartSciences' Merger Partner Fortitude Upsizes DCG Credit Facility to $50 Million
MT Newswires Live  ·  09-24
HeartSciences' Merger Partner Fortitude Upsizes DCG Credit Facility to $50 Million
Fortitude Mining Holdings: Dcg May Fund $31 Mln Commitment in Zec Instead of U.S. Dollars
THOMSON REUTERS  ·  09-24
Fortitude Mining Holdings: Dcg May Fund $31 Mln Commitment in Zec Instead of U.S. Dollars
No data available

Introduction

Company Name.
HeartSciences Inc
Affiliated Markets:
NASDAQ
Listing Date:
--
Main Business:
Heart Test Laboratories, Inc., doing business as HeartSciences, is a medical technology company focuses on applying AI-based technology to an ECG to expand and improve an ECG's clinical utility. It is developing AI-ECG solutions to be made available on a hardware agnostic cloud-based platform or its proprietary MyoVista wavECG device, to help identify cardiovascular disease in any care setting worldwide in a manner to suit different care providers. Its first product candidate for FDA clearance, the MyoVista wavECG, or the MyoVista, is a resting 12-lead ECG that is designed to provide diagnostic information related to cardiac dysfunction. The MyoVista also provides conventional ECG information in the same test. The company was incorporated in 2007 and is headquartered in Southlake, Texas.
Issue price:
--